Mani Foroohar

Stock Analyst at Leerink Partners

(1.48)
# 3,157
Out of 4,765 analysts
182
Total ratings
41.18%
Success rate
-14.15%
Average return

Stocks Rated by Mani Foroohar

Recursion Pharmaceuticals
Feb 28, 2025
Maintains: Market Perform
Price Target: $7$6
Current: $6.15
Upside: -2.44%
4D Molecular Therapeutics
Jan 13, 2025
Maintains: Outperform
Price Target: $31$27
Current: $4.34
Upside: +522.84%
Rocket Pharmaceuticals
Nov 19, 2024
Maintains: Outperform
Price Target: $46$44
Current: $8.73
Upside: +404.01%
Lexeo Therapeutics
Nov 13, 2024
Maintains: Outperform
Price Target: $20$19
Current: $3.12
Upside: +508.97%
Neurogene
Nov 12, 2024
Maintains: Outperform
Price Target: $45$72
Current: $17.22
Upside: +318.12%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: $17
Current: $5.43
Upside: +213.08%
Mirum Pharmaceuticals
Oct 17, 2024
Maintains: Outperform
Price Target: $47$49
Current: $45.18
Upside: +8.46%
BridgeBio Pharma
Oct 17, 2024
Maintains: Outperform
Price Target: $47$46
Current: $32.95
Upside: +39.63%
Wave Life Sciences
Oct 16, 2024
Maintains: Outperform
Price Target: $20$22
Current: $10.38
Upside: +112.05%
Ionis Pharmaceuticals
Jul 24, 2024
Upgrades: Outperform
Price Target: $53$62
Current: $33.00
Upside: +87.88%
Initiates: Outperform
Price Target: $13
Current: $15.29
Upside: -14.97%
Initiates: Outperform
Price Target: $29
Current: $22.71
Upside: +27.70%
Maintains: Outperform
Price Target: $165$230
Current: $99.54
Upside: +131.06%
Downgrades: Market Perform
Price Target: $12$4
Current: $3.12
Upside: +28.21%
Upgrades: Outperform
Price Target: n/a
Current: $7.52
Upside: -
Initiates: Outperform
Price Target: $31
Current: $5.32
Upside: +483.25%
Downgrades: Market Perform
Price Target: $23
Current: $9.12
Upside: +152.19%
Initiates: Outperform
Price Target: $7
Current: $0.68
Upside: +933.36%
Downgrades: Market Perform
Price Target: $40
Current: $15.41
Upside: +159.57%
Downgrades: Underperform
Price Target: $111$93
Current: $35.43
Upside: +162.48%
Maintains: Outperform
Price Target: $86$84
Current: $9.46
Upside: +787.95%
Maintains: Market Perform
Price Target: $6$7
Current: $1.43
Upside: +389.51%
Maintains: Market Perform
Price Target: $180$160
Current: $3.78
Upside: +4,134.26%
Maintains: Outperform
Price Target: $81$77
Current: $25.74
Upside: +199.20%
Maintains: Market Perform
Price Target: $144$143
Current: $240.70
Upside: -40.59%
Maintains: Market Perform
Price Target: $5$6
Current: $5.38
Upside: +11.52%
Maintains: Outperform
Price Target: $75$76
Current: $43.24
Upside: +75.76%
Maintains: Outperform
Price Target: $30$34
Current: $1.01
Upside: +3,266.67%
Maintains: Market Perform
Price Target: $50$20
Current: $4.60
Upside: +334.78%